Tags

Type your tag names separated by a space and hit enter

Impact of delayed presentation on management and outcome of non-ST-elevation acute coronary syndromes.
Am Heart J. 2008 Aug; 156(2):262-8.AH

Abstract

BACKGROUND

The impact of delayed presentation on the management and outcomes of patients with non-ST-elevation acute coronary syndromes (NSTE-ACS) has not been well studied. Furthermore, the prognostic value of initial biomarker level in relation to the time of presentation has not been determined.

METHODS

The Canadian ACS II registry was a national, multicenter, prospective observational study of 1,956 patients with NSTE-ACS (October 2002-December 2003). We compared the baseline characteristics, treatment, and outcomes in early (within 6 hours of symptom onset) versus late presenters (>6 hours). A logistic regression model was developed to examine the independent association of late presentation with 1-year mortality. We also evaluated the prognostic value of initial biomarker level in relation to early versus late presentation.

RESULTS

A total of 1,219 (62.3%) patients presented early, whereas 727 (37.7%) presented late; their rates of in-hospital revascularization were similar (40.5% vs 42.5%, respectively, P = .39). There was also no significant difference in hospital mortality (1.6% vs 2.2%, P = .30) or 1-year mortality (7.6% vs 5.7%, P = .13) between early and late presenters. After adjusting for other prognosticators, late presentation was not an independent predictor of 1-year mortality (adjusted odds ratio 0.78, 95% confidence interval 0.48-1.26, P = .3). Elevated initial biomarker was independently associated with higher 1-year mortality (adjusted odds ratio 2.17, 95% CI 1.31-3.58, P = .002) regardless of whether hospital presentation was early or late (P for interaction = .74).

CONCLUSIONS

There is still considerable delay between symptom onset of NSTE-ACS and hospital presentation in the contemporary era. In contrast to studies of ST-elevation myocardial infarction, we found no significant differences in the management and outcome of early presenters as compared with late presenters with NSTE-ACS. Nevertheless, measures to reduce patient delay time should continue to be implemented. Initial biomarker status is a useful prognosticator irrespective of the delay time.

Authors+Show Affiliations

Terrence Donnelly Heart Centre, Division of Cardiology, St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Comparative Study
Journal Article
Multicenter Study

Language

eng

PubMed ID

18657655

Citation

Elbarouni, Basem, et al. "Impact of Delayed Presentation On Management and Outcome of non-ST-elevation Acute Coronary Syndromes." American Heart Journal, vol. 156, no. 2, 2008, pp. 262-8.
Elbarouni B, Goodman SG, Yan RT, et al. Impact of delayed presentation on management and outcome of non-ST-elevation acute coronary syndromes. Am Heart J. 2008;156(2):262-8.
Elbarouni, B., Goodman, S. G., Yan, R. T., Casanova, A., Al-Hesayen, A., Pearce, S., Fitchett, D. H., Langer, A., & Yan, A. T. (2008). Impact of delayed presentation on management and outcome of non-ST-elevation acute coronary syndromes. American Heart Journal, 156(2), 262-8. https://doi.org/10.1016/j.ahj.2008.03.025
Elbarouni B, et al. Impact of Delayed Presentation On Management and Outcome of non-ST-elevation Acute Coronary Syndromes. Am Heart J. 2008;156(2):262-8. PubMed PMID: 18657655.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Impact of delayed presentation on management and outcome of non-ST-elevation acute coronary syndromes. AU - Elbarouni,Basem, AU - Goodman,Shaun G, AU - Yan,Raymond T, AU - Casanova,Amparo, AU - Al-Hesayen,Abdul, AU - Pearce,Stephen, AU - Fitchett,David H, AU - Langer,Anatoly, AU - Yan,Andrew T, AU - ,, Y1 - 2008/06/17/ PY - 2007/12/04/received PY - 2008/03/21/accepted PY - 2008/7/29/pubmed PY - 2008/8/6/medline PY - 2008/7/29/entrez SP - 262 EP - 8 JF - American heart journal JO - Am. Heart J. VL - 156 IS - 2 N2 - BACKGROUND: The impact of delayed presentation on the management and outcomes of patients with non-ST-elevation acute coronary syndromes (NSTE-ACS) has not been well studied. Furthermore, the prognostic value of initial biomarker level in relation to the time of presentation has not been determined. METHODS: The Canadian ACS II registry was a national, multicenter, prospective observational study of 1,956 patients with NSTE-ACS (October 2002-December 2003). We compared the baseline characteristics, treatment, and outcomes in early (within 6 hours of symptom onset) versus late presenters (>6 hours). A logistic regression model was developed to examine the independent association of late presentation with 1-year mortality. We also evaluated the prognostic value of initial biomarker level in relation to early versus late presentation. RESULTS: A total of 1,219 (62.3%) patients presented early, whereas 727 (37.7%) presented late; their rates of in-hospital revascularization were similar (40.5% vs 42.5%, respectively, P = .39). There was also no significant difference in hospital mortality (1.6% vs 2.2%, P = .30) or 1-year mortality (7.6% vs 5.7%, P = .13) between early and late presenters. After adjusting for other prognosticators, late presentation was not an independent predictor of 1-year mortality (adjusted odds ratio 0.78, 95% confidence interval 0.48-1.26, P = .3). Elevated initial biomarker was independently associated with higher 1-year mortality (adjusted odds ratio 2.17, 95% CI 1.31-3.58, P = .002) regardless of whether hospital presentation was early or late (P for interaction = .74). CONCLUSIONS: There is still considerable delay between symptom onset of NSTE-ACS and hospital presentation in the contemporary era. In contrast to studies of ST-elevation myocardial infarction, we found no significant differences in the management and outcome of early presenters as compared with late presenters with NSTE-ACS. Nevertheless, measures to reduce patient delay time should continue to be implemented. Initial biomarker status is a useful prognosticator irrespective of the delay time. SN - 1097-6744 UR - https://www.unboundmedicine.com/medline/citation/18657655/Impact_of_delayed_presentation_on_management_and_outcome_of_non_ST_elevation_acute_coronary_syndromes_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0002-8703(08)00278-0 DB - PRIME DP - Unbound Medicine ER -